Clinical Research
The Company That Wants to Make the Endocannabinoid System as Measurable as Blood Sugar
Dr Stefan Broselid, Founder and Scientific Lead of ECS Restore, has filed a patent application for a non-cannabinoid formulation designed to treat dysfunction in the endocannabinoid system (ECS), moving his research from scientific hypothesis towards a meaningful commercial proposition.
